Production (Stage)
ANI Pharmaceuticals, Inc.
ANIP
$57.79
$0.520.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 155.19M | 151.17M | 153.28M | 247.05M | 238.25M |
| Total Receivables | 220.33M | 221.73M | 196.36M | 166.09M | 172.42M |
| Inventory | 137.41M | 136.78M | 148.04M | 125.45M | 113.84M |
| Prepaid Expenses | 23.13M | 17.78M | 17.28M | 13.70M | 15.75M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 234.00K | 233.00K | 6.34M | 3.17M | 300.00K |
| Total Current Assets | 536.29M | 527.68M | 521.30M | 555.46M | 540.56M |
|
|
|||||
| Total Current Assets | 536.29M | 527.68M | 521.30M | 555.46M | 540.56M |
| Net Property, Plant & Equipment | 58.18M | 56.86M | 56.70M | 51.64M | 48.53M |
| Long-term Investments | 60.66M | 59.99M | 60.43M | 28.22M | 28.22M |
| Goodwill | 60.66M | 59.99M | 60.43M | 28.22M | 28.22M |
| Total Other Intangibles | 538.50M | 541.83M | 569.83M | 183.08M | 196.04M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 98.80M | 92.43M | 75.53M | 94.95M | 93.48M |
| Total Assets | 1.29B | 1.28B | 1.29B | 920.75M | 914.52M |
|
|
|||||
| Total Accounts Payable | 53.06M | 45.66M | 60.89M | 48.68M | 49.43M |
| Total Accrued Expenses | 80.68M | 90.76M | 83.54M | 55.71M | 41.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.19M | 11.21M | 7.15M | 850.00K | 850.00K |
| Total Finance Division Other Current Liabilities | 56.88M | 46.05M | 38.35M | 34.74M | 44.67M |
| Total Other Current Liabilities | 56.88M | 46.05M | 38.35M | 34.74M | 44.67M |
| Total Current Liabilities | 201.82M | 193.68M | 189.93M | 139.98M | 136.89M |
|
|
|||||
| Total Current Liabilities | 201.82M | 193.68M | 189.93M | 139.98M | 136.89M |
| Long-Term Debt | 611.63M | 614.92M | 618.21M | 284.39M | 284.61M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.02M | 4.55M | 6.94M | 4.68M | 5.06M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 28.49M | 42.02M | 41.49M | 11.09M | 11.16M |
| Total Liabilities | 848.96M | 855.17M | 856.58M | 440.14M | 437.71M |
|
|
|||||
| Common Stock & APIC | 531.06M | 519.66M | 510.90M | 532.50M | 523.63M |
| Retained Earnings | -85.00M | -100.28M | -89.60M | -65.03M | -62.33M |
| Treasury Stock & Other | -27.43M | -15.70M | -15.36M | -11.71M | -9.34M |
| Total Common Equity | 418.62M | 403.68M | 405.95M | 455.76M | 451.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 24.85M | 24.85M | 24.85M | 24.85M | 24.85M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 24.85M | 24.85M | 24.85M | 24.85M | 24.85M |
|
|
|||||
| Total Common Equity | 418.62M | 403.68M | 405.95M | 455.76M | 451.96M |
| Total Preferred Equity | 24.85M | 24.85M | 24.85M | 24.85M | 24.85M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 443.47M | 428.53M | 430.80M | 480.61M | 476.81M |
|
|
|||||